APA (7th ed.) Citation

VF, V., GL, D., AD, B., D, E., W, S., JJ, V., . . . KA, D. (2022). A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): Results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 27(26), . https://doi.org/10.2807/1560-7917.ES.2022.27.26.2100704

Chicago Style (17th ed.) Citation

VF, Viprey, et al. "A Point-prevalence Study on Community and Inpatient Clostridioides Difficile Infections (CDI): Results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018." Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 27, no. 26 (2022). https://doi.org/10.2807/1560-7917.ES.2022.27.26.2100704.

MLA (9th ed.) Citation

VF, Viprey, et al. "A Point-prevalence Study on Community and Inpatient Clostridioides Difficile Infections (CDI): Results from Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI), July to November 2018." Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, vol. 27, no. 26, 2022, https://doi.org/10.2807/1560-7917.ES.2022.27.26.2100704.